Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2
Supplementary Data
Supplementary Data
Files in this Data Supplement:
Supplementary Data
- Doc file
Supplementary Figure 1
- tif file
Supplementary Table 1
- docx file
Supplementary Table 2
- docx file